The product was approved out of the Unit VII (SEZ) formulations facility in Hyderabad.
Aurobindo Pharma gets USFDA nod for anti-hypertension drug
New Delhi, April 30:Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Quinapril tablets. The tablet is generic equivalent of Pfizer Pharmaceuticals Ltd's Accupril tablets and
New Delhi, April 30:Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Quinapril tablets. The tablet is generic equivalent of Pfizer Pharmaceuticals Ltd's Accupril tablets and are indicated for the treatment of hypertension.
Read all the Breaking News Live on indiatvnews.com and Get Latest English News & Updates from Business and India Section
Advertisement
Advertisement
-
Tata Steel to merge European operations with Thyssenkrupp to create 2nd largest steel behemoth
-
Bengaluru: I-T raids on S M Krishna’s son-in-law Siddhartha, owner of Cafe Coffee Day chain
-
5 reasons why TRAI’s decision on IUC cut will significantly boost RIL’s earnings
-
GST interim returns: Over 75 per cent eligible taxpayers waited for last day to file returns, says Jaitley
-
India replaces China as top retail destination in 2017: Study
Top News
-
7 dead, 13 injured as water, debris enter tunnel in Uttarakhand's Chamoli; 2 still trapped | Updates
-
Amid reports of sailors jumping off USS Abraham Lincoln, US dispatches replacement warship to Middle
-
Prabhas' Salaar 2 enters pre-production as Prashanth Neel reunites with producer for sequel
-
Vinay Kumar named new Karnataka head coach ahead of upcoming domestic season
Advertisement
Advertisement